Arabic Arabic English English French French German German
dark

FDA Approves First-of-its-Kind Automated Insulin Delivery and Monitoring System for Use in Young Pediatric Patients

FDA approved the MiniMed 770G System, a hybrid closed loop diabetes management device that is intended to automatically monitor glucose (sugar) and provide appropriate basal insulin doses with little or no input from the users or their caregivers for use by individuals aged 2 to 6 with type 1 diabet Read More

Total
0
Shares
Leave a Reply

Your email address will not be published. Required fields are marked *

Previous Post

New Methods Boost Scale of Single-Cell Gene Expression Dynamics Studies

Next Post

Body Mass Index is a More Powerful Risk Factor for Diabetes Than Genetics

Related Posts
Total
0
Share